Simona D. Esposti
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity." Am J Ophthalmol. 2020; 219:87-100.
Journal: American journal of ophthalmology
Published: August 03, 2025
Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events.
Journal: American journal of hematology
Published: July 04, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" [Am J Ophthalmol 2020;219:87-100].
Journal: American journal of ophthalmology
Published: March 08, 2025
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.
Journal: Journal of the advanced practitioner in oncology
Published: October 09, 2023
Paracentral acute middle maculopathy following COVID-19.
Journal: Arquivos brasileiros de oftalmologia
Published: April 03, 2023
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Journal: Blood cancer journal
Published: June 27, 2022
Partial recovery of visual function in a blind patient after optogenetic therapy.
Journal: Nature medicine
Published: November 23, 2020
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis.
Journal: Ocular immunology and inflammation
Published: November 17, 2020
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population.
Journal: Ocular immunology and inflammation
Published: August 18, 2020
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis.
Journal: Ocular immunology and inflammation
Published: July 01, 2020
Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6.
Journal: Ocular immunology and inflammation
Published: July 01, 2020
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis.
Journal: Ocular immunology and inflammation
Published: June 27, 2020
Last Updated: 09/26/2026